Smart Pills Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Smart Pills Market

1.1. Definition and Scope

1.1.1. Definition of Smart Pills

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Smart Pills Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Smart Pills Market By Application Area

1.2.3. Smart Pills Market By Disease Indication

1.2.4. Smart Pills Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Smart Pills Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Smart Pills Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Price Trend of Key Raw Material

3.8.1. Raw Material Suppliers

3.8.2. Proportion of Manufacturing Cost Structure

3.8.2.1. Raw Material

3.8.2.2. Labor Cost

3.8.2.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Smart Pills Market By Application Area

5.1. Introduction

5.2. Smart Pills Revenue By Application Area

5.2.1. Smart Pills Revenue (USD Million) and Forecast, By Application Area, 2020-2032

5.2.2. Capsule Endoscopy

5.2.2.1. Capsule Endoscopy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2. Colon Capsule Endoscopy

5.2.2.2.1. Colon Capsule Endoscopy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3. Small Bowel Video Capsule Endoscopy

5.2.2.3.1. Small Bowel Video Capsule Endoscopy Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Drug Delivery

5.2.3.1. Drug Delivery Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Patient Monitoring

5.2.4.1. Patient Monitoring Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Smart Pills Market By Disease Indication

6.1. Introduction

6.2. Smart Pills Revenue By Disease Indication

6.2.1. Smart Pills Revenue (USD Million) and Forecast, By Disease Indication, 2020-2032

6.2.2. Occult GI Bleeding

6.2.2.1. Occult GI Bleeding Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Small Bowel Tumors

6.2.3.1. Small Bowel Tumors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Crohn's Disease

6.2.4.1. Crohn's Disease Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Celiac Disease

6.2.5.1. Celiac Disease Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. Neurological Disorders

6.2.6.1. Neurological Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.7. Inherited Polyposis Syndromes

6.2.7.1. Inherited Polyposis Syndromes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.8. Others

6.2.8.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. North America Smart Pills Market By Country 

7.1. North America Smart Pills Market Overview

7.2. U.S.

7.2.1. U.S. Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

7.2.2. U.S. Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

7.3. Canada

7.3.1. Canada Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

7.3.2. Canada Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

7.4. North America PEST Analysis

CHAPTER 8. Europe Smart Pills Market By Country

8.1. Europe Smart Pills Market Overview

8.2. U.K.

8.2.1. U.K. Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

8.2.2. U.K. Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

8.3. Germany

8.3.1. Germany Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

8.3.2. Germany Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

8.4. France

8.4.1. France Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

8.4.2. France Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

8.5. Spain

8.5.1. Spain Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

8.5.2. Spain Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

8.6. Rest of Europe

8.6.1. Rest of Europe Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

8.6.2. Rest of Europe Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Smart Pills Market By Country

9.1. Asia Pacific Smart Pills Market Overview

9.2. China

9.2.1. China Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.2.2. China Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.3. Japan

9.3.1. Japan Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.3.2. Japan Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.4. India

9.4.1. India Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.4.2. India Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.5. Australia

9.5.1. Australia Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.5.2. Australia Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.6. South Korea

9.6.1. South Korea Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.6.2. South Korea Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

9.7.2. Rest of Asia-Pacific Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Smart Pills Market By Country

10.1. Latin America Smart Pills Market Overview

10.2. Brazil

10.2.1. Brazil Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

10.2.2. Brazil Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

10.3. Mexico

10.3.1. Mexico Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

10.3.2. Mexico Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

10.4. Rest of Latin America

10.4.1. Rest of Latin America Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

10.4.2. Rest of Latin America Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Smart Pills Market By Country 

11.1. Middle East & Africa Smart Pills Market Overview

11.2. GCC

11.2.1. GCC Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

11.2.2. GCC Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

11.3. South Africa

11.3.1. South Africa Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

11.3.2. South Africa Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Smart Pills Revenue (USD Million) and Forecast By Application Area, 2020-2032

11.4.2. Rest of Middle East & Africa Smart Pills Revenue (USD Million) and Forecast By Disease Indication, 2020-2032

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Smart Pills Market

12.1. Smart Pills Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Smart Pills Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Proteus Digital Health, Inc.

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Million), 2022

13.1.3.2. Proteus Digital Health, Inc. 2022 Smart Pills Business Regional Distribution

13.1.4. Product/Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Medtronic plc

13.3. Capsule Technologies, Inc.

13.4. Philips Healthcare

13.5. Proteus Biomedical

13.6. Given Imaging Ltd.

13.7. IntroMedic Co., Ltd.

13.8. Olympus Corporation

13.9. Bio-Images Research Limited

13.10. Medisafe Inc.

13.11. VitalConnect, Inc.

13.12. HQ Inc.